Kim Rathbone

A plan backed by millions of dollars is raising serious concerns for animal welfare advocates in the United States. Billionaire investor Joe Lonsdale, co-founder of Palantir, has backed Safer Human Medicine with a reported $20 million investment. The company wants to establish a massive breeding operation in Georgia that could eventually house up to 30,000 monkeys for medical research. The animals would primarily be long-tailed macaques, intelligent and social primates that are already classified as endangered. The company says the United States needs a reliable domestic supply of monkeys for biomedical research. It argues that relying on overseas suppliers has created serious supply problems for American research facilities. But many people are asking a different question. Should the answer be to breed tens of thousands of monkeys for laboratory experiments? These animals are not products on an assembly line. They are social creatures with complex needs. They form bonds, experience stress and need space to live in conditions that support their well-being. The proposal has also faced strong opposition from local residents and animal protection groups. Concerns have been raised about animal welfare, public health and the impact such a large facility could have on the surrounding community. There is another part of this story worth remembering. The founder of Safer Human Medicine previously worked as an executive at Envigo, the company involved in a major animal welfare scandal over its treatment of thousands of beagles. Envigo later pleaded guilty to federal animal welfare violations. The proposed Georgia facility is not yet operating. But the plan raises important questions about the future of animal testing in America. Medical research matters. Finding treatments for serious diseases matters. But should progress come at the cost of breeding tens of thousands of intelligent animals for experiments? Science is also making progress with human cell-based research, organ-on-a-chip technology and other alternatives that could reduce the need for animal testing. We should be asking how much more can be done to advance these methods.